NASDAQ:CARA
$3.09
(
0%
)
Friday, 2nd Jun 2023
Cara Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.99 | $4.67 | Friday, 2nd Jun 2023 CARA stock ended at $3.09. During the day the stock fluctuated 8.29% from a day low at $2.99 to a day high of $3.24. |
| 90 days | $2.99 | $10.28 | |
| 52 weeks | $2.99 | $12.98 |
Historical Cara Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $3.13 | $3.24 | $2.99 | $3.09 | 1 618 926 |
| 2023-06-01 | $3.20 | $3.27 | $3.05 | $3.09 | 998 409 |
| 2023-05-31 | $3.42 | $3.45 | $3.17 | $3.18 | 1 943 761 |
| 2023-05-30 | $3.48 | $3.48 | $3.34 | $3.44 | 749 381 |
| 2023-05-26 | $3.39 | $3.42 | $3.24 | $3.40 | 617 037 |
| 2023-05-25 | $3.50 | $3.54 | $3.25 | $3.28 | 814 442 |
| 2023-05-24 | $3.69 | $3.69 | $3.51 | $3.51 | 605 906 |
| 2023-05-23 | $3.71 | $3.83 | $3.68 | $3.70 | 521 256 |
| 2023-05-22 | $3.76 | $3.81 | $3.67 | $3.71 | 659 261 |
| 2023-05-19 | $3.90 | $3.93 | $3.70 | $3.79 | 907 142 |
| 2023-05-18 | $4.20 | $4.21 | $3.79 | $3.85 | 896 942 |
| 2023-05-17 | $4.46 | $4.48 | $4.17 | $4.20 | 932 975 |
| 2023-05-16 | $4.38 | $4.67 | $4.11 | $4.45 | 2 710 528 |
| 2023-05-15 | $4.04 | $4.16 | $3.99 | $4.15 | 889 836 |
| 2023-05-12 | $4.05 | $4.11 | $3.91 | $4.00 | 462 323 |
| 2023-05-11 | $4.15 | $4.15 | $4.00 | $4.03 | 365 214 |
| 2023-05-10 | $4.26 | $4.29 | $4.07 | $4.15 | 453 721 |
| 2023-05-09 | $4.25 | $4.32 | $4.16 | $4.18 | 379 523 |
| 2023-05-08 | $4.38 | $4.41 | $4.24 | $4.28 | 403 911 |
| 2023-05-05 | $4.40 | $4.42 | $4.29 | $4.39 | 296 521 |
| 2023-05-04 | $4.20 | $4.36 | $4.13 | $4.35 | 352 247 |
| 2023-05-03 | $4.11 | $4.29 | $4.08 | $4.21 | 377 778 |
| 2023-05-02 | $4.23 | $4.31 | $4.03 | $4.09 | 517 266 |
| 2023-05-01 | $4.20 | $4.25 | $4.16 | $4.23 | 239 084 |
| 2023-04-28 | $4.06 | $4.27 | $4.03 | $4.20 | 552 065 |
| 2023-04-27 | $4.01 | $4.14 | $3.99 | $4.05 | 335 797 |
| 2023-04-26 | $3.93 | $4.08 | $3.89 | $4.00 | 552 203 |
| 2023-04-25 | $3.96 | $4.15 | $3.90 | $3.93 | 506 567 |
| 2023-04-24 | $4.10 | $4.15 | $3.92 | $4.00 | 491 542 |
| 2023-04-21 | $4.09 | $4.22 | $4.03 | $4.10 | 545 489 |
| 2023-04-20 | $4.19 | $4.19 | $4.03 | $4.07 | 485 941 |
| 2023-04-19 | $4.22 | $4.28 | $4.17 | $4.20 | 405 226 |
| 2023-04-18 | $4.48 | $4.51 | $4.23 | $4.26 | 647 839 |
| 2023-04-17 | $4.26 | $4.47 | $4.23 | $4.43 | 1 201 201 |
| 2023-04-14 | $4.55 | $4.56 | $4.20 | $4.23 | 418 279 |
| 2023-04-13 | $4.29 | $4.61 | $4.29 | $4.57 | 598 675 |
| 2023-04-12 | $4.52 | $4.59 | $4.25 | $4.27 | 468 908 |
| 2023-04-11 | $4.46 | $4.61 | $4.40 | $4.46 | 506 923 |
| 2023-04-10 | $4.60 | $4.62 | $4.41 | $4.61 | 489 389 |
| 2023-04-06 | $4.71 | $4.75 | $4.59 | $4.62 | 471 048 |
| 2023-04-05 | $4.72 | $4.96 | $4.67 | $4.71 | 605 454 |
| 2023-04-04 | $4.91 | $4.95 | $4.57 | $4.74 | 983 567 |
| 2023-04-03 | $4.89 | $5.04 | $4.82 | $4.94 | 827 338 |
| 2023-03-31 | $4.93 | $5.06 | $4.90 | $4.91 | 824 247 |
| 2023-03-30 | $5.09 | $5.20 | $4.77 | $4.89 | 654 156 |
| 2023-03-29 | $4.99 | $5.12 | $4.97 | $5.08 | 449 002 |
| 2023-03-28 | $5.04 | $5.12 | $4.90 | $4.94 | 426 506 |
| 2023-03-27 | $4.99 | $5.19 | $4.95 | $5.05 | 493 489 |
| 2023-03-24 | $5.01 | $5.09 | $4.85 | $4.92 | 493 971 |
| 2023-03-23 | $5.25 | $5.33 | $4.94 | $5.06 | 676 083 |
About Cara Therapeutics
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
